Study Information
Locations
Clinical Trial FAQs
Information for patients and study volunteers, including frequently asked questions.
Description
Outside Co-Investigators include Kate Rendle, PhD, National Cancer Institute, and Allison Kurian, MD, Stanford University School of Medicine.
Funder
Stanford University (California Breast Cancer Research Program and the Richard and Susan Levy Fund)
Related Studies
Cancer Liquid Biopsy Monitoring Study
Investigators: Deepti Behl, MD, Mohammed Kashani-Sabet, M.D.
COVID-19 Impacts on Cancer Care Management, Patient Experience and Care Costs
Investigators: Cheryl Stults, Ph.D., Su-Ying Liang, Ph.D., Monique de Bruin, M.D., MPH
Stupski Serious Illness Program Evaluation
Investigator: Sylvia Sudat, PhD
Impact of COVID-19 on Cancer Care Management
Investigators: Su-Ying Liang, Ph.D., Monique de Bruin, M.D., MPH
Coverage, Price, and Reimbursement for Multigene Tests for Cancer and Related Conditions
Investigator: Su-Ying Liang, Ph.D.
Improving Cancer Care
Investigator: Su-Ying Liang, Ph.D.
Multilevel Study of Lung Cancer Screening Guidelines Implementation (MUST)
Investigator: Jiang Li, Ph.D., MPH
Implementing Universal Lynch Syndrome Screening Across Multiple Healthcare Systems: Identifying Strategies to Facilitate and Maintain Programs in Different Organizations Contexts
Investigators: Monique de Bruin, M.D., MPH, External PI, Principal Investigator, Su-Ying Liang, Ph.D.
Lung Cancer in Never Smokers: Incidence, Risk Factors and Molecular Characteristics in Asian American, Native Hawaiian, and Pacific Islander (AANHPI) Women
Investigators: Su-Ying Liang, Ph.D., External PI, Principal Investigator